| abstract |
Disclosed are novel C-β-D-xylopyranoside series compounds which are expected to have an inhibitive effect on cancers, vascular sclerosis, thrombus and the like. The C-β-D-xylopyranoside series compounds are represented by the following general formula:n in which R denotes a lower alkyl group having from 1 to 5 carbon atoms. n There are also described pharmaceutical composition, which are especially effective against cancer, vascular sclerosis, thrombus etc. |